Welcome to the 544th Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days.
The highlights of this week's edition are randomised controlled trials comparing 8 with 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia & temporary transvenous phrenic nerve stimulation in difficult-to-wean patients; systematic reviews and meta analyses comparing high dose with low dose corticosteroids in COVID-19 patients & the effects of goal-directed fluid therapy on renal function; and observational studies investigating peri-intubation cardiovascular collapse in critically ill patients and a comparison of 6-month outcomes of critically ill survivors of COVID-19 with non–COVID-19 critically ill survivors. There are also guidelines on resuscitative endovascular balloon occlusion of the aorta & intravenous fluids; narrative reviews on ECMO in COVID-19 & prolonged mechanical ventilation; editorials on cardiac manifestations in critically ill patients with COVID-19 & whole blood for trauma resuscitation; and commentaries on whether informed consent should be obtained for apnea testing in the determination of death by neurologic criteria.
If you only have time to read one review article this week, try this one on the pathophysiology of polytrauma.
Critical Care Reviews Meeting 2022
There are just 4 weeks to CCR22, featuring the best critical care trials in the world. If you plan on attending, you better be quick! Registration for CCR22, on June 15th to 17th at Titanic Belfast, is open.
My Intensive Care
For the past year Critical Care Reviews has been supported by My Intensive Care, a med tech company providing a digital management platform for intensive care units. My Intensive Care is active across mobile, tablet and browser and allows departments to have a single source for all their content across clinical guidelines, training, education, staff communication as well as much more.